Funding news
Degron Therapeutics logo

Degron Therapeutics Raises $40.0

Recently funded · $40.0M Series aHospitals and Health CareUSView source

Get the full Degron Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A new class of targeted protein degradation therapeutics just got a significant boost, with Degron Therapeutics announcing it has closed its Series A funding round, securing $40.0M. The biotech firm aims to become a global leader in developing small molecule molecular glue degrader (MGD) drugs, focusing on disease targets previously considered undruggable.

The investment round drew support from LAPAM CAPITAL, GTJA Investment Group, Fortune Capital, and CSPC & Growth. Degron plans to leverage its scientific expertise to identify and validate novel selective MGD compounds, addressing unmet medical needs across all therapeutic areas.

Targeting the “undruggable” with molecular glue technology for more funding business information follow GrowthEagle Degron Therapeutics,CSPC Pharmaceutical Group,Biorun (Nature BioTechnology Co.),TechCrunch  Another breakthrough in biotech innovation!

Clinical-stage biotech startup Degron Therapeutics has raised a $40M Series A Extension to accelerate the development of its molecular glue degrader (MGD) platform a next-gen approach targeting previously “undruggable” proteins. Led by LAPAM CAPITAL, with participation from GTJA Investment Group, Fortune Capital, CSPC & Growth, this funding highlights the growing investor confidence in precision m

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Kohort logo

Kohort

India

$5.2M
2
Exponent logo

Exponent

United States

$7.7M
3
Nectar Social logo

Nectar Social

United States

$30.0M
4
GridCARE logo

GridCARE

United States

$64.0M
5
Novella logo

Novella

United States

$21.0M